cd38 inhibitor and 5-amino-1mq synergy nad+ CD38-expressing macrophages drive age-related decline Inhibition of CD38 enzymatic activity
Inhibition of CD38 enzymatic activity enhances CAR T cell immune therapeutic efficacy by repressing glycolytic metabolism ScienceDirect Emerging chemical strategies for CD38 inhibition: restoring NAD+ metabolism and disease control ScienceDirect CD38 connects the heart and brain Translational Psychiatry The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC CD38 as a Regulator of Cellular NAD: A Novel Potential Pharmacological Target for Metabolic Conditions PMC
Pay in 4 interest-free payments of $7.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




